Recent Updates
Recently added Catalysts
CTMX Positive Sentiment

CytomX Therapeutics to Present at Upcoming March Investor Conferences

Tuesday, February 27, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: CytomX Therapeutics, Inc. (Nasdaq: CTMX) has announced its participation in several investor conferences in March 2024, including the TD Cowen’s 44th Annual Health Care Conference and the Barclays 26th Annual Global Healthcare Conference. The events will feature formal presentations and a fireside chat, which will be accessible via live webcasts on the company's website. Additionally, CytomX's management will be available for one-on-one meetings with registered investors.
Price reaction · baseline $1.65 (2024-02-26 close) · hit after-hours · clean, no other CTMX news in the window
day 0 close
+36.4%
day 1
+53.9%
day 3 · peak
+60.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • CytomX Therapeutics is actively engaging with investors by participating in key conferences.
  • The management is available for one-on-one meetings, indicating a commitment to fostering investor relations.
  • The company's presentations may provide valuable insights into its innovative approaches in biologics.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+53%
120-day peak, hindsight
Typical move
6.8%
average across 7 past catalysts
Cash runway
~54 mo
Minimal dilution risk
Lead asset
CX-2009
Phase 2 · Neoplasms

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that management will participate in the following investor conferences in March.
TD Cowen’s 44th Annual Health Care Conference
Date: Tuesday, March 5, 2024
Formal Presentation: 2:50 p.m. ET
Location: Boston, MA
Barclays 26th Annual Global Healthcare Conference
Date: Thursday, March 14, 2024
Fireside Chat: 11:45 p.m. ET
Live webcasts of the TD Cowen presentation and Barclays fireside chat will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conferences.
About CytomX Therapeutics
Probody is a U.S. registered trademark of CytomX Therapeutics, Inc.
SVP, Finance and Accounting
Direct: (317) 767-4764
Investor and Media Contact:

Frequently Asked Questions

When is the TD Cowen Health Care Conference?

The TD Cowen Health Care Conference is on March 5, 2024.

What time will CytomX present at the TD Cowen conference?

CytomX's formal presentation is at 2:50 p.m. ET.

Where is the Barclays Global Healthcare Conference held?

The Barclays Global Healthcare Conference is in Boston, MA.

How can I watch CytomX's presentations live?

Live webcasts will be on CytomX’s Events and Presentations page.

Will CytomX management meet with investors?

Yes, management will have one-on-one meetings with registered investors.

ShareAdd on Google
Tags: CTMX Viatris Investor Conferences Healthcare CytomX Therapeutics investor conferences health care biologics
Last updated: Feb 27, 2024

Biotech snapshot

Cash runway
$330M liquidity · $6M/mo burn
~54 mo
Minimal dilution risk
Lead asset
CX-2009Phase 2
Neoplasms →

Catalyst track record

+53%
best trade around CTMX's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for CTMX.

See every catalyst's timing & PoA →